Mandadi Tilak 4
4 · CVS HEALTH Corp · Filed Dec 3, 2024
Insider Transaction Report
Form 4
Mandadi Tilak
EVP, Chief Experience & Tech
Transactions
- Award
Common Stock (RSU)
2024-11-30$59.85/sh+50,125$2,999,981→ 99,747 total
Holdings
- 96,496
Stock Option
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (96,496 underlying) - 40,414
Common Stock
- 67,920
Stock Option
Exercise: $79.56From: 2025-04-01Exp: 2034-04-01→ Common Stock (67,920 underlying)
Footnotes (3)
- [F1]Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 11/30/2025.
- [F2]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.
- [F3]Option becomes exercisable in four equal annual installments, commencing 4/1/2025.